Weak Trigger
now
Clinches US Department of Defense contract for supply and joint development of placenta-derived cell therapies designed to counter Acute Radiation Syndrome (ARS).
24h Trigger History
No history available
No trigger updates found for this ticker in the last 24 hours.
| Advertisement |